These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 38945330

  • 1. Tetrastigma hemsleyanum polysaccharide combined with doxorubicin promote ferroptosis and immune function in triple-negative breast cancer.
    Shang Y, Zhao M, Chen S, Chen Y, Liu X, Zhou F, Li Y, Long M, Xu K, Ding Z, Wang L.
    Int J Biol Macromol; 2024 Aug; 275(Pt 1):133424. PubMed ID: 38945330
    [Abstract] [Full Text] [Related]

  • 2. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
    Gong G, Ganesan K, Liu Y, Huang Y, Luo Y, Wang X, Zhang Z, Zheng Y.
    J Ethnopharmacol; 2024 Apr 06; 323():117655. PubMed ID: 38158099
    [Abstract] [Full Text] [Related]

  • 3. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
    Ding Y, Chen X, Liu C, Ge W, Wang Q, Hao X, Wang M, Chen Y, Zhang Q.
    J Hematol Oncol; 2021 Jan 20; 14(1):19. PubMed ID: 33472669
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effects of polysaccharides from Tetrastigma hemsleyanum Diels et Gilg via regulation of intestinal flora and enhancing immunomodulatory effects in vivo.
    Zhou F, Lu Y, Sun T, Sun L, Wang B, Lu J, Li Z, Zhu B, Huang S, Ding Z.
    Front Immunol; 2022 Jan 20; 13():1009530. PubMed ID: 36389762
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel Withanolides from Tubocapsicum anomalum Suppress Triple-Negative Breast Cancer by Triggering Apoptosis and p53-ASCT2-SLC7A11-Mediated Ferroptosis.
    Huang L, Wei Y, Ni M, Hu H, Xi L, Wang C, Zhu Z, Yang B, Zhao H.
    Molecules; 2024 Apr 18; 29(8):. PubMed ID: 38675657
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.
    Yuan SJ, Xu YH, Wang C, An HC, Xu HZ, Li K, Komatsu N, Zhao L, Chen X.
    J Nanobiotechnology; 2019 Oct 17; 17(1):110. PubMed ID: 31623629
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tetrastigma hemsleyanum polysaccharide ameliorates cytokine storm syndrome via the IFN-γ-JAK2/STAT pathway.
    Fu S, Bao X, Mao Z, Lv Y, Zhu B, Chen Y, Zhou M, Tian S, Zhou F, Ding Z.
    Int J Biol Macromol; 2024 Aug 17; 275(Pt 1):133427. PubMed ID: 38936586
    [Abstract] [Full Text] [Related]

  • 17. Ferroptosis as a promising targeted therapy for triple negative breast cancer.
    Mokhtarpour K, Razi S, Rezaei N.
    Breast Cancer Res Treat; 2024 Oct 17; 207(3):497-513. PubMed ID: 38874688
    [Abstract] [Full Text] [Related]

  • 18. Tetrastigma hemsleyanum polysaccharide ameliorated ulcerative colitis by remodeling intestinal mucosal barrier function via regulating the SOCS1/JAK2/STAT3 pathway.
    Bao X, Tang Y, Lv Y, Fu S, Yang L, Chen Y, Zhou M, Zhu B, Ding Z, Zhou F.
    Int Immunopharmacol; 2024 Aug 20; 137():112404. PubMed ID: 38851163
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.